The impact of congenital thrombotic thrombocytopenic purpura on pregnancy complications.
Anne-Sophie von Krogh, Department of Haematology, St Olavs Hospital Trondheim University Hospital, PO Box 3250 Sluppen, N-7006 Trondheim, Norway, Tel.: +47 72825367/ +47 48233320, Fax: + 47 72825733, E-mail: anne-sophie.v.krogh@ntnu.no.
Anne-Sophie
AS
von Krogh
Johanna A
JA
Kremer Hovinga
Geir E
GE
Tjønnfjord
Ingrid M
IM
Ringen
Bernhard
B
Lämmle
Anders
A
Waage
Petter
P
Quist-Paulsen
D051722:ADAM Proteins / Q000097:blood / Q000235:genetics; D000071120:ADAMTS13 Protein; D000293:Adolescent; D000328:Adult; D000368:Aged; D003430:Cross-Sectional Studies; D005260:Female; D017359:HELLP Syndrome / Q000097:blood / Q000209:etiology; D006801:Humans; D007231:Infant, Newborn; D008875:Middle Aged; D009154:Mutation; D011225:Pre-Eclampsia / Q000097:blood / Q000209:etiology; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood / Q000209:etiology*; D011256:Pregnancy Outcome; D011697:Purpura, Thrombotic Thrombocytopenic / Q000150:complications* / Q000151:congenital* / Q000235:genetics; D012189:Retrospective Studies; D055815:Young Adult
D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human